Related Experiment Video
Updated: May 29, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
Published on: June 10, 2020
Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular
Cherilyn A Elwell1, Shaobo Jiang, Jung Hwa Kim
1Department of Medicine, University of California, San Francisco, California, United States of America.
Abstract:
The strain designated Chlamydia trachomatis serovar that was used for experiments in this paper is Chlamydia muridarum, a species closely related to C. trachomatis (and formerly termed the Mouse Pneumonitis strain of C. trachomatis. [corrected]. The obligate intracellular pathogen Chlamydia trachomatis replicates within a membrane-bound inclusion that acquires host sphingomyelin (SM), a process that is essential for replication as well as inclusion biogenesis. Previous studies demonstrate that SM is acquired by a Brefeldin A (BFA)-sensitive vesicular trafficking pathway, although paradoxically, this pathway is dispensable for bacterial replication. This finding suggests that other lipid transport mechanisms are involved in the acquisition of host SM. In this work, we interrogated the role of specific components of BFA-sensitive and BFA-insensitive lipid trafficking pathways to define their contribution in SM acquisition during infection. We found that C. trachomatis hijacks components of both vesicular and non-vesicular lipid trafficking pathways for SM acquisition but that the SM obtained from these separate pathways is being utilized by the pathogen in different ways. We show that C. trachomatis selectively co-opts only one of the three known BFA targets, GBF1, a regulator of Arf1-dependent vesicular trafficking within the early secretory pathway for vesicle-mediated SM acquisition. The Arf1/GBF1-dependent pathway of SM acquisition is essential for inclusion membrane growth and stability but is not required for bacterial replication. In contrast, we show that C. trachomatis co-opts CERT, a lipid transfer protein that is a key component in non-vesicular ER to trans-Golgi trafficking of ceramide (the precursor for SM), for C. trachomatis replication. We demonstrate that C. trachomatis recruits CERT, its ER binding partner, VAP-A, and SM synthases, SMS1 and SMS2, to the inclusion and propose that these proteins establish an on-site SM biosynthetic factory at or near the inclusion. We hypothesize that SM acquired by CERT-dependent transport of ceramide and subsequent conversion to SM is necessary for C. trachomatis replication whereas SM acquired by the GBF1-dependent pathway is essential for inclusion growth and stability. Our results reveal a novel mechanism by which an intracellular pathogen redirects SM biosynthesis to its replicative niche.
Insights
Chlamydia trachomatis hijacks host sphingomyelin (SM) using both vesicular and non-vesicular pathways. One pathway aids inclusion growth, while another supports bacterial replication by creating a local SM factory.
Area of Science:
- Microbiology
- Cell Biology
- Biochemistry
Background:
- Chlamydia trachomatis is an obligate intracellular pathogen that replicates within a host-derived membrane-bound inclusion.
- Sphingomyelin (SM) acquisition by the inclusion is crucial for Chlamydia replication and inclusion biogenesis.
- Previous studies indicated SM acquisition via a Brefeldin A (BFA)-sensitive pathway, but this pathway is dispensable for replication, suggesting alternative mechanisms.
Purpose of the Study:
- To investigate the roles of BFA-sensitive and BFA-insensitive lipid trafficking pathways in sphingomyelin (SM) acquisition by Chlamydia trachomatis.
- To define how Chlamydia trachomatis utilizes SM obtained through different lipid acquisition pathways.
Main Methods:
- Interrogation of specific components within BFA-sensitive and BFA-insensitive lipid trafficking pathways.
- Analysis of the contribution of GBF1 (a BFA target) and CERT (a non-vesicular lipid transfer protein) in SM acquisition.
- Investigation of the recruitment of CERT, VAP-A, and SM synthases (SMS1, SMS2) to the inclusion.
Main Results:
- Chlamydia trachomatis utilizes both vesicular (GBF1-dependent) and non-vesicular (CERT-dependent) pathways for SM acquisition.
- The Arf1/GBF1-dependent pathway is essential for inclusion membrane growth and stability but not bacterial replication.
- The CERT-dependent pathway, involving ceramide transport and on-site SM synthesis, is critical for Chlamydia replication.
Conclusions:
- Chlamydia trachomatis employs distinct lipid trafficking pathways to acquire SM for different essential functions.
- The GBF1 pathway supports inclusion biogenesis, while the CERT pathway facilitates bacterial replication through localized SM synthesis.
- This study reveals a novel mechanism of pathogen-host lipid manipulation, where Chlamydia redirects host SM biosynthesis to its replicative niche.
Related Concept Videos
Bacterial Phylum Chlamydiae
Trichomoniasis
Fungal Phylum Microsporidia
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Bacterial Phylum Spirochaetes

